<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="rdf.xsl"?>
<rdf:RDF  xmlns="http://purl.org/rss/1.0/"
				  xmlns:dc="http://purl.org/dc/elements/1.1/
					xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
					
<channel rdf:about="http://livepress.com">
          <title>Merck			
 - livepress.com</title>
      <link>http://Merck			
.livepress.com</link>
      <description>Updated every 15 minutes of every day - FOR PERSONAL USE ONLY</description>
  <dc:publisher>livepress.com</dc:publisher>
  <dc:creator>livepress.com</dc:creator>
  <dc:rights>Copyright &#169; 2006 livepress.com</dc:rights>
  <sy:updatePeriod>hourly</sy:updatePeriod>
  <sy:updateFrequency>2</sy:updateFrequency>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://livepress.com" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://livepress.com/go/?132116">
  		<title><![CDATA[Merck not liable for man's health woes 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?132116</link>
  		  		<dc:description><![CDATA[AP - A jury on Wednesday found pharmaceutical company  Merck  &amp; Co. not liable for causing an elderly man's heart ailments after he took the drug maker's once-popular painkiller Vioxx.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?130843">
  		<title><![CDATA[Opening arguments begin in Vioxx trial 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?130843</link>
  		  		<dc:description><![CDATA[    AP - The second federal plaintiff to claim that the painkiller Vioxx caused a heart attack was a fit retired FBI agent who watched his diet, exercised regularly and was a model patient, his lawyer says.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?130087">
  		<title><![CDATA[Husband and Wife Legal Team Passionately Defend the Rights of Vioxx Plaintiffs]]></title>
	  	<link>http://livepress.com/go/?130087</link>
  		  		<dc:description><![CDATA[   As time runs short for potential Vioxx plaintiffs to file claims against  Merck  &amp; Company, the drug&#8217;s manufacturer, a team of Houston attorneys work diligently on behalf of their clients and potential plaintiffs. 

                        

      ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?125819">
  		<title><![CDATA[Merck doubles profits despite GlycoFi charge 
    (AFP)
]]></title>
	  	<link>http://livepress.com/go/?125819</link>
  		  		<dc:description><![CDATA[    AFP - US pharmaceutical group  Merck  and Co announced a doubling of its quarterly net profits despite having to absorb a hefty charge related to its acquisition of biotech firm GlycoFi, Inc.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?125813">
  		<title><![CDATA[Merck Doubles Quarterly Earnings]]></title>
	  	<link>http://livepress.com/go/?125813</link>
  		  		<dc:description><![CDATA[On Monday, drugmaker  Merck  &amp; Co. Inc. raised its 2006 profit forecast and said that its quarterly earnings had doubled. The New Jersey based company stated that it earned $1.50 billion, or 69 cents per share, in the second quarter. In comparison, they made $721 million, or 33 cents per share,...]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?125685">
  		<title><![CDATA[Merck profit doubles, raises 2006 forecast 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?125685</link>
  		  		<dc:description><![CDATA[    Reuters -  Merck  & Co.  on Monday said its 
second-quarter earnings more than doubled on growing demand for 
its drugs, blowing past Wall Street expectations, and raised 
its full-year profit forecast.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?125612">
  		<title><![CDATA[Merck poised to rise as Street remains wary: report 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?125612</link>
  		  		<dc:description><![CDATA[    Reuters -  Merck  & Co. Inc. , knocked low 
by the recall of its arthritis drug Vioxx, is poised to rise 
because Wall Street has failed to appreciate cost cutting and 
new products likely to generate bigger-than-expected sales, a 
report said.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?125554">
  		<title><![CDATA[Merck poised to rise as Street remains wary: report 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?125554</link>
  		  		<dc:description><![CDATA[Reuters -  Merck  & Co. Inc. , knocked low 
by the recall of its arthritis drug Vioxx, is poised to rise 
because Wall Street has failed to appreciate cost cutting and 
new products likely to generate bigger-than-expected sales, a 
report said.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?123308">
  		<title><![CDATA[Lawmaker alleges FDA, Merck collaborated 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?123308</link>
  		  		<dc:description><![CDATA[AP - A federal health official worked with drug maker  Merck  to discredit a government whistleblower who publicized safety risks associated with the painkiller Vioxx, a lawmaker alleged Wednesday in seeking an investigation.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?121070">
  		<title><![CDATA[Jurors rule for Merck in N.J. Vioxx case 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?121070</link>
  		  		<dc:description><![CDATA[    AP - Elaine Doherty was the typical patient to whom drug maker  Merck  &amp;amp; Co. marketed its former  blockbuster  painkiller Vioxx: a senior citizen with  arthritis  and other ailments common among older folks, including heart disease.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?120782">
  		<title><![CDATA[NJ Jury Rules Vioxx Not Substantial Factor In Heart Attack Suit]]></title>
	  	<link>http://livepress.com/go/?120782</link>
  		  		<dc:description><![CDATA[A jury on Thursday ruled  Merck  &amp; Co.'s withdrawn pain medicine Vioxx was not a substantial factor in the heart attack of Elaine Doherty, a 68-year-old New Jersey woman. The jury of five men and two women also decided that although  Merck  failed to warn the plaintiff Doherty about the heart...]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?120747">
  		<title><![CDATA[Merck wins latest Vioxx case]]></title>
	  	<link>http://livepress.com/go/?120747</link>
  		  		<dc:description><![CDATA[Merck was found not liable in the seventh lawsuit over Vioxx, the arthritis painkiller that it pulled from the market because of heart attack risk, the company announced Thursday.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?120746">
  		<title><![CDATA[Jury absolves Merck in N.J. Vioxx case 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?120746</link>
  		  		<dc:description><![CDATA[    AP -  Merck  &amp;amp; Co. won a crucial legal victory on Thursday, when jurors decided that the drugmaker&#039;s Vioxx painkiller, now the subject of at least 16,000 product liability lawsuits, did not cause a 68-year-old woman&#039;s heart attack.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?120691">
  		<title><![CDATA[NJ jury finds Vioxx not a major heart attack factor 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?120691</link>
  		  		<dc:description><![CDATA[    Reuters - A jury on Thursday found 
 Merck  &amp; Co.&#039;s  withdrawn pain medicine Vioxx was not a 
substantial factor in the heart attack of a 68-year-old New 
Jersey woman.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?119819">
  		<title><![CDATA[Deliberations start in 7th Vioxx trial 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?119819</link>
  		  		<dc:description><![CDATA[    AP - Jurors in the seventh trial over withdrawn painkiller Vioxx began deliberating Wednesday morning over the plaintiff&#039;s claim that the former  Merck  &amp;amp; Co. drug caused her 2004 heart attack.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?119078">
  		<title><![CDATA[Jury hears closing arguments in Vioxx case 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?119078</link>
  		  		<dc:description><![CDATA[    AP - Severely clogged arteries, obesity and other factors caused a 68-year-old grandmother&#039;s heart attack &amp;#151; not her use of Vioxx, lawyers for the drug&#039;s maker told jurors during closing arguments Tuesday in New Jersey&#039;s latest case over the withdrawn painkiller.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?118239">
  		<title><![CDATA[Drug cos. set sights on diabetes care 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?118239</link>
  		  		<dc:description><![CDATA[AP - Drug companies are racing to capture the ballooning market in  diabetes  care.  Pfizer  Inc. plans to debut Exubera, its new inhaled insulin treatment, in July, and  Merck  &amp; Co., Novartis AG and  Eli Lilly  and Co. are awaiting FDA approval for new  diabetes  products that could generate hundreds of millions of dollars in sales.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?117992">
  		<title><![CDATA[Drug cos. set sights on diabetes care 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?117992</link>
  		  		<dc:description><![CDATA[AP - Drug companies are racing to capture the ballooning market in diabetes care.  Pfizer  Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and  Merck  &amp; Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?115381">
  		<title><![CDATA[Teens should get cervical cancer vaccine: panel 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?115381</link>
  		  		<dc:description><![CDATA[Reuters - All young girls age 11 and 12 should 
take  Merck  and Co.'s vaccine to prevent  cervical cancer , as 
should 13- to 26-years-olds if they have not received it 
already, U.S. advisers decided on Thursday.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?113317">
  		<title><![CDATA[Study correction shows early Vioxx risks 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?113317</link>
  		  		<dc:description><![CDATA[AP - A correction published Monday by a medical journal to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people took the drug and did not develop only after 18 months of use as the drug's maker,  Merck  &amp; Co., has contended.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?113057">
  		<title><![CDATA[Study correction shows early Vioxx risk 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?113057</link>
  		  		<dc:description><![CDATA[AP - A correction published Monday to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people were on the drug and did not develop only after 18 months of use as the drug's maker,  Merck  &amp; Co., has contended.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?111760">
  		<title><![CDATA[Zocor and Zoloft Patents To Expire]]></title>
	  	<link>http://livepress.com/go/?111760</link>
  		  		<dc:description><![CDATA[Zocor, a cholesterol-cutting drug from  Merck  and Zoloft, antidepressant from  Pfizer  are going off patent this month. Merck's patent for Zocor expires Friday while Zoloft loses patent protection on June 30.
                    
                
                
                    ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?111667">
  		<title><![CDATA[FDA approves generic versions of Zocor 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?111667</link>
  		  		<dc:description><![CDATA[AP - The first generic versions of Zocor, the widely used  cholesterol  drug made by  Merck  &amp; Co. Inc., received federal approval Friday.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?111566">
  		<title><![CDATA[Merck KGaA drops Parkinson's drug after clinical trials fail 
    (AFP)
]]></title>
	  	<link>http://livepress.com/go/?111566</link>
  		  		<dc:description><![CDATA[    AFP -  Merck  KGaA -- the German drug maker that lost a takeover battle for Schering -- has said it is binning Saritozan, the drug it was developing to treat Parkinson&#039;s disease, after Phase III clinical trials failed.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?111470">
  		<title><![CDATA[Merck KGaA drops Parkinson's drug after clinical trials fail 
    (AFP)
]]></title>
	  	<link>http://livepress.com/go/?111470</link>
  		  		<dc:description><![CDATA[    AFP -  Merck  KGaA -- the German drug maker that lost a takeover battle for Schering -- has said it is binning Saritozan, the drug it was developing to treat Parkinson&#039;s disease, after Phase III clinical trials failed.  ]]></dc:description>
  				</item>
</rdf:RDF>